Location: Mountain View, CA
CIK: 0001652044 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $2.58B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASTS | AST SPACEMOBILE INC | 8,943,486 | $650M | 25.2% | $25.58 | +179.0% | COM CL A | 00217D100 |
| PL | PLANET LABS PBC | 31,942,641 | $630M | 24.4% | $9.47 | +51.3% | COM CL A | 72703X106 |
| RVMD | REVOLUTION MEDICINES INC | 3,345,102 | $266M | 10.3% | $24.03 | +172.9% | COM | 76155X100 |
| ARM | ARM HOLDINGS PLC | 1,960,784 | $214M | 8.3% | $53.52 | — | SPONSORED ADS | 042068205 |
| FRSH | FRESHWORKS INC | 16,206,643 | $199M | 7.7% | $22.50 | -47.5% | CLASS A COM | 358054104 |
| PATH | UIPATH INC | 7,034,337 | $115M | 4.5% | $73.33 | -78.8% | CL A | 90364P105 |
| GTLB | GITLAB INC | 2,724,712 | $102M | 4.0% | $59.42 | -27.1% | CLASS A COM | 37637K108 |
| TEM | TEMPUS AI INC | 1,551,102 | $91.59M | 3.6% | $30.66 | +155.1% | CL A | 88023B103 |
| DXCM | DEXCOM INC | 1,036,937 | $68.82M | 2.7% | $99.11 | -34.8% | COM | 252131107 |
| MAZE | MAZE THERAPEUTICS INC | 1,388,583 | $57.53M | 2.2% | $12.04 | +185.5% | COM | 578784100 |
| PRME | PRIME MEDICINE INC | 16,562,498 | $57.47M | 2.2% | $14.77 | -69.9% | COM | 74168J101 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $35.35M | 1.4% | $11.58 | — | COM NEW | 107924102 |
| RLAY | RELAY THERAPEUTICS INC | 1,568,753 | $13.27M | 0.5% | $37.40 | -80.9% | COM | 75943R102 |
| VERA | VERA THERAPEUTICS INC | 241,264 | $12.22M | 0.5% | $15.54 | +128.6% | CL A | 92337R101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 744,948 | $11.68M | 0.5% | $20.37 | -33.8% | COM | 61225M102 |
| SANA | SANA BIOTECHNOLOGY INC | 2,812,500 | $11.45M | 0.4% | $32.56 | -86.2% | COM | 799566104 |
| LYEL | LYELL IMMUNOPHARMA INC | 293,256 | $9.026M | 0.3% | $9.11 | +145.6% | COM NEW | 55083R203 |
| BEAM | BEAM THERAPEUTICS INC | 321,604 | $8.915M | 0.3% | $21.73 | +17.4% | COM | 07373V105 |
| FIG | FIGMA INC | 215,582 | $8.056M | 0.3% | $68.66 | -34.2% | CLASS A COM STK | 316841105 |
| OSCR | OSCAR HEALTH INC | 481,988 | $6.926M | 0.3% | $31.30 | -44.7% | CL A | 687793109 |
| WGS | GENEDX HOLDINGS CORP | 22,711 | $2.954M | 0.1% | $33.78 | +306.4% | COM | 81663L200 |
| EXAS | EXACT SCIENCES CORP | 23,205 | $2.357M | 0.1% | $105.58 | -23.9% | COM | 30063P105 |
| SPRO | SPERO THERAPEUTICS INC | 889,979 | $2.074M | 0.1% | $12.27 | -81.1% | COM | 84833T103 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 698,262 | $1.39M | 0.1% | $26.79 | — | SPON ADS | 05280R100 |
| HYPR | HYPERFINE INC | 898,720 | $881K | 0.0% | $9.78 | -87.7% | COM CL A | 44916K106 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $650K | 0.0% | $21.49 | -93.7% | COM | 87990A106 |
| QNCX | QUINCE THERAPEUTICS INC | 189,122 | $634K | 0.0% | $29.87 | -91.6% | COM | 22053A107 |
| FULC | FULCRUM THERAPEUTICS INC | 14,262 | $161K | 0.0% | $11.14 | -8.7% | COM | 359616109 |
| RGEN | REPLIGEN CORP | 383 | $62,758 | 0.0% | $269.41 | -41.9% | COM | 759916109 |